# Penske Automotive Group, Inc.: financial statements, quarterly

PAG · NYSE · CIK 1019849 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pag.md) · [Financials](/companies/pag/financials.md) · [Filings](/companies/pag/filings.md) · [Insiders](/companies/pag/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pag/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8,661 d](/filings/0001628280-26-012830.md) | [7,793](/filings/0001628280-26-012830.md) | [8,065](/filings/0001628280-26-012830.md) | [7,930](/filings/0001628280-26-012830.md) | [8,078](/filings/0001628280-26-012830.md) | [7,954](/filings/0001628280-26-028868.md) | [8,033](/filings/0001628280-26-051036.md) | [8,053](/filings/0001628280-26-068213.md) | [7,769](/filings/0001628280-26-012830.md) | [7,864](/filings/0001628280-26-028868.md) | [8,513](/filings/0001628280-26-051036.md) | [8,416](/filings/0001628280-26-068213.md) |
| Cost of revenue | $m | [7,260 d](/filings/0001628280-26-012830.md) | [6,203](/filings/0001019849-25-000050.md) | [6,433](/filings/0001019849-25-000097.md) | [6,348](/filings/0001628280-25-047533.md) | [7,665 d](/filings/0001628280-26-012830.md) | [6,632](/filings/0001628280-26-028868.md) | [6,680](/filings/0001628280-26-051036.md) | [6,753](/filings/0001628280-26-068213.md) | [6,525 d](/filings/0001628280-26-012830.md) | [6,564](/filings/0001628280-26-028868.md) | [7,156](/filings/0001628280-26-051036.md) | [7,092](/filings/0001628280-26-068213.md) |
| Gross profit | $m | [1,402 d](/filings/0001628280-26-012830.md) | [1,294](/filings/0001628280-26-012830.md) | [1,316](/filings/0001628280-26-012830.md) | [1,294](/filings/0001628280-26-012830.md) | [1,313](/filings/0001628280-26-012830.md) | [1,321](/filings/0001628280-26-028868.md) | [1,352](/filings/0001628280-26-051036.md) | [1,300](/filings/0001628280-26-068213.md) | [1,244](/filings/0001628280-26-012830.md) | [1,299](/filings/0001628280-26-028868.md) | [1,357](/filings/0001628280-26-051036.md) | [1,324](/filings/0001628280-26-068213.md) |
| Selling, general and administrative | $m | [997 d](/filings/0001628280-26-012830.md) | [880](/filings/0001019849-25-000050.md) | [888](/filings/0001019849-25-000097.md) | [885](/filings/0001628280-25-047533.md) | [1,033 d](/filings/0001628280-26-012830.md) | [951](/filings/0001628280-26-028868.md) | [944](/filings/0001628280-26-051036.md) | [945](/filings/0001628280-26-068213.md) | [924 d](/filings/0001628280-26-012830.md) | [966](/filings/0001628280-26-028868.md) | [974](/filings/0001628280-26-051036.md) | [976](/filings/0001628280-26-068213.md) |
| Operating income | $m | [324 d](/filings/0001628280-26-012830.md) | [328](/filings/0001019849-25-000050.md) | [338](/filings/0001019849-25-000097.md) | [317](/filings/0001628280-25-047533.md) | [387 d](/filings/0001628280-26-012830.md) | [329](/filings/0001628280-26-028868.md) | [365](/filings/0001628280-26-051036.md) | [311](/filings/0001628280-26-068213.md) | [275 d](/filings/0001628280-26-012830.md) | [289](/filings/0001628280-26-028868.md) | [338](/filings/0001628280-26-051036.md) | [303](/filings/0001628280-26-068213.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [63.8 d](/filings/0001628280-26-012830.md) | [78.6](/filings/0001019849-25-000050.md) | [82.6](/filings/0001019849-25-000097.md) | [77.4](/filings/0001628280-25-047533.md) | [77.9 d](/filings/0001628280-26-012830.md) | [92.1](/filings/0001628280-26-028868.md) | [86.0](/filings/0001628280-26-051036.md) | [78.7](/filings/0001628280-26-068213.md) | [69.0 d](/filings/0001628280-26-012830.md) | [88.8](/filings/0001628280-26-028868.md) | [92.6](/filings/0001628280-26-051036.md) | [80.8](/filings/0001628280-26-068213.md) |
| Net income | $m | [246 d](/filings/0001628280-26-012830.md) | [227](/filings/0001628280-26-012830.md) | [255](/filings/0001628280-26-012830.md) | [238](/filings/0001628280-26-012830.md) | [249](/filings/0001628280-26-012830.md) | [258](/filings/0001628280-26-028868.md) | [267](/filings/0001628280-26-051036.md) | [225](/filings/0001628280-26-068213.md) | [186](/filings/0001628280-26-012830.md) | [235](/filings/0001628280-26-028868.md) | [260](/filings/0001628280-26-051036.md) | [221](/filings/0001628280-26-068213.md) |
| Diluted EPS | $ per share | not reported | [3.38](/filings/0001628280-26-012830.md) | [3.81](/filings/0001628280-26-012830.md) | [3.57](/filings/0001628280-26-012830.md) | [3.73](/filings/0001628280-26-012830.md) | [3.86](/filings/0001628280-26-028868.md) | [4.03](/filings/0001628280-26-051036.md) | [3.41](/filings/0001628280-26-068213.md) | [2.83](/filings/0001628280-26-012830.md) | [3.56](/filings/0001628280-26-028868.md) | [3.96](/filings/0001628280-26-051036.md) | [3.36](/filings/0001628280-26-068213.md) |
| Basic EPS | $ per share | not reported | [3.21](/filings/0001019849-25-000050.md) | [3.61](/filings/0001019849-25-000097.md) | [3.39](/filings/0001628280-25-047533.md) | not reported | [3.86](/filings/0001628280-26-028868.md) | [4.03](/filings/0001628280-26-051036.md) | [3.41](/filings/0001628280-26-068213.md) | [2.83](/filings/0001628280-26-012830.md) | [3.56](/filings/0001628280-26-028868.md) | [3.96](/filings/0001628280-26-051036.md) | [3.36](/filings/0001628280-26-068213.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001019849-25-000022.md) | [0.1](/filings/0001019849-24-000058.md) | [0.1](/filings/0001019849-24-000096.md) | [0.1](/filings/0001019849-24-000121.md) | [0.1](/filings/0001628280-26-012830.md) | [0.1](/filings/0001019849-25-000050.md) | [0.2](/filings/0001019849-25-000097.md) | [0.1](/filings/0001628280-25-047533.md) | [0.1](/filings/0001628280-26-068213.md) | [0.1](/filings/0001628280-26-028868.md) | [0.1](/filings/0001628280-26-051036.md) | [0.1](/filings/0001628280-26-068213.md) |
| Current assets | $bn | [5.7](/filings/0001019849-25-000022.md) | [5.8](/filings/0001019849-24-000058.md) | [6.1](/filings/0001019849-24-000096.md) | [6.2](/filings/0001019849-24-000121.md) | [6.0](/filings/0001628280-26-012830.md) | [6.1](/filings/0001019849-25-000050.md) | [6.3](/filings/0001019849-25-000097.md) | [6.0](/filings/0001628280-25-047533.md) | [6.2](/filings/0001628280-26-068213.md) | [6.3](/filings/0001628280-26-028868.md) | [6.5](/filings/0001628280-26-051036.md) | [6.4](/filings/0001628280-26-068213.md) |
| Total assets | $bn | [15.7](/filings/0001019849-25-000022.md) | [16.1](/filings/0001019849-24-000058.md) | [16.6](/filings/0001019849-24-000096.md) | [17.1](/filings/0001019849-24-000121.md) | [17.1](/filings/0001628280-26-012830.md) | [16.9](/filings/0001019849-25-000050.md) | [17.4](/filings/0001019849-25-000097.md) | [17.1](/filings/0001628280-25-047533.md) | [17.6](/filings/0001628280-26-068213.md) | [18.3](/filings/0001628280-26-028868.md) | [18.5](/filings/0001628280-26-051036.md) | [18.4](/filings/0001628280-26-068213.md) |
| Current liabilities | $bn | [5.7](/filings/0001019849-25-000022.md) | [5.9](/filings/0001019849-24-000058.md) | [6.2](/filings/0001019849-24-000096.md) | [6.8](/filings/0001019849-24-000121.md) | [6.6](/filings/0001628280-26-012830.md) | [6.7](/filings/0001019849-25-000050.md) | [7.0](/filings/0001019849-25-000097.md) | [6.2](/filings/0001628280-25-047533.md) | [6.3](/filings/0001628280-26-068213.md) | [6.6](/filings/0001628280-26-028868.md) | [6.7](/filings/0001628280-26-051036.md) | [6.5](/filings/0001628280-26-068213.md) |
| Total liabilities | $bn | [10.9](/filings/0001019849-25-000022.md) | [11.3](/filings/0001019849-24-000058.md) | [11.6](/filings/0001019849-24-000096.md) | [11.8](/filings/0001019849-24-000121.md) | [11.7](/filings/0001628280-26-012830.md) | [11.5](/filings/0001019849-25-000050.md) | [11.8](/filings/0001019849-25-000097.md) | [11.4](/filings/0001628280-25-047533.md) | [12.0](/filings/0001628280-26-068213.md) | [12.6](/filings/0001628280-26-028868.md) | [12.7](/filings/0001628280-26-051036.md) | [12.5](/filings/0001628280-26-068213.md) |
| Long-term debt | $bn | [1.4](/filings/0001019849-25-000022.md) | [1.5](/filings/0001019849-24-000058.md) | [1.6](/filings/0001019849-24-000096.md) | [1.1](/filings/0001019849-24-000121.md) | [1.1](/filings/0001628280-26-012830.md) | [1.0](/filings/0001019849-25-000050.md) | [0.9](/filings/0001019849-25-000097.md) | [1.3](/filings/0001628280-25-047533.md) | [1.8](/filings/0001628280-26-068213.md) | [2.2](/filings/0001628280-26-028868.md) | [2.1](/filings/0001628280-26-051036.md) | [2.1](/filings/0001628280-26-068213.md) |
| Current portion of debt | $bn | [0.2](/filings/0001019849-25-000022.md) | [0.2](/filings/0001019849-24-000058.md) | [0.2](/filings/0001019849-24-000096.md) | [0.7](/filings/0001019849-24-000121.md) | [0.7](/filings/0001628280-26-012830.md) | [0.8](/filings/0001019849-25-000050.md) | [0.9](/filings/0001019849-25-000097.md) | [0.3](/filings/0001628280-25-047533.md) | [0.4](/filings/0001628280-26-068213.md) | [0.4](/filings/0001628280-26-028868.md) | [0.4](/filings/0001628280-26-051036.md) | [0.3](/filings/0001628280-26-068213.md) |
| Shareholders' equity | $bn | [4.7](/filings/0001019849-25-000022.md) | [4.8](/filings/0001019849-24-000058.md) | [5.0](/filings/0001019849-24-000096.md) | [5.2](/filings/0001019849-24-000121.md) | [5.4](/filings/0001628280-26-012830.md) | [5.4](/filings/0001019849-25-000050.md) | [5.6](/filings/0001019849-25-000097.md) | [5.7](/filings/0001628280-25-047533.md) | [5.6](/filings/0001628280-26-068213.md) | [5.7](/filings/0001628280-26-028868.md) | [5.8](/filings/0001628280-26-051036.md) | [5.9](/filings/0001628280-26-068213.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [123 d](/filings/0001628280-26-012830.md) | [456](/filings/0001019849-25-000050.md) | [235 d](/filings/0001019849-25-000097.md) | [271 d](/filings/0001628280-25-047533.md) | [269 d](/filings/0001628280-26-012830.md) | [291](/filings/0001628280-26-028868.md) | [209 d](/filings/0001628280-26-051036.md) | [399 d](/filings/0001628280-26-068213.md) | [75.7 d](/filings/0001628280-26-012830.md) | [215](/filings/0001628280-26-028868.md) | [204 d](/filings/0001628280-26-051036.md) | [306 d](/filings/0001628280-26-068213.md) |
| Capital expenditure | $m | [114 d](/filings/0001628280-26-012830.md) | [103](/filings/0001019849-25-000050.md) | [99.2](/filings/0001019849-25-000097.md) | [80.9](/filings/0001628280-25-047533.md) | [95.2 d](/filings/0001628280-26-012830.md) | [84.7](/filings/0001628280-26-028868.md) | [70.8](/filings/0001019849-25-000097.md) | [79.1](/filings/0001628280-25-047533.md) | [85.3 d](/filings/0001628280-26-012830.md) | [62.6](/filings/0001628280-26-028868.md) | [72.3 d](/filings/0001628280-26-051036.md) | [82.2 d](/filings/0001628280-26-068213.md) |
| Dividends paid | $m | [53.3 d](/filings/0001628280-26-012830.md) | [58.6](/filings/0001019849-25-000050.md) | [64.4 d](/filings/0001019849-25-000097.md) | [71.7 d](/filings/0001628280-25-047533.md) | [79.7 d](/filings/0001628280-26-012830.md) | [81.8](/filings/0001628280-26-028868.md) | [83.6 d](/filings/0001628280-26-051036.md) | [87.3 d](/filings/0001628280-26-068213.md) | [91.1 d](/filings/0001628280-26-012830.md) | [92.6](/filings/0001628280-26-028868.md) | [93.6 d](/filings/0001628280-26-051036.md) | [94.8 d](/filings/0001628280-26-068213.md) |
| Share repurchases | $m | [17.5 d](/filings/0001628280-26-012830.md) | [32.9](/filings/0001019849-25-000050.md) | [25.2 d](/filings/0001019849-25-000097.md) | [0.0 d](/filings/0001628280-25-047533.md) | [0.6 d](/filings/0001628280-26-012830.md) | [39.9](/filings/0001628280-26-028868.md) | [71.3 d](/filings/0001628280-26-051036.md) | [7.8 d](/filings/0001628280-26-068213.md) | [40.1 d](/filings/0001628280-26-012830.md) | [26.3](/filings/0001628280-26-028868.md) | [0.0 d](/filings/0001628280-26-051036.md) | [0.0 d](/filings/0001628280-26-068213.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.2](/filings/0001019849-24-000058.md) | [68.2](/filings/0001019849-24-000096.md) | [67.3](/filings/0001019849-24-000121.md) | [67.1](/filings/0001019849-25-000050.md) | [66.9](/filings/0001019849-25-000097.md) | [66.8](/filings/0001628280-25-047533.md) | [66.8](/filings/0001628280-26-028868.md) | [66.2](/filings/0001628280-26-051036.md) | [66.0](/filings/0001628280-26-068213.md) | [65.8](/filings/0001628280-26-028868.md) | [65.7](/filings/0001628280-26-051036.md) | [65.7](/filings/0001628280-26-068213.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,661,728 at 2026-10-19, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068213.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:59 ET. No prices; not investment advice.